| Mrs Tatiana Buch, | |
|
555 Middlefield Rd, Palo Alto, CA 94301-2124 | |
| (857) 275-5659 | |
| Not Available |
| Full Name | Mrs Tatiana Buch |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 555 Middlefield Rd, Palo Alto, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003395963 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Tatiana Buch, 555 Middlefield Rd, Palo Alto, CA 94301-2124 Ph: (857) 275-5659 | Mrs Tatiana Buch, 555 Middlefield Rd, Palo Alto, CA 94301-2124 Ph: (857) 275-5659 |
News Archive
As pressure mounts on state Medicaid budgets, the New York Times examines whether the programs can handle the influx expected under the new health law. And The Hill looks at the latest waivers awarded by the administration for insurance plans that don't meet the requirements of the law.
Now patients with mild to moderate plaque psoriasis have a new topical treatment option available by prescription. Zithranol™-RR (anthralin rapid release microcrystalline encapsulated cream, 1.2%), is an innovative topical therapy for plaque psoriasis according to Elorac, Inc., a privately held emerging dermatology company. Zithranol™-RR provides an advanced delivery system for anthralin achieving long remission times with no long-term side effects in a steroid-free, silky cream.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office has granted European patent No. 2099765 to Rexahn, entitled "5, 6, or 7-Substituted-3-arylisoquinolinamine derivatives as antitumor agents."
Idera Pharmaceuticals, Inc. announced today that it is presenting preclinical data from a study evaluating the mechanism of action of one of its Toll-like receptor (TLR) 7 and TLR9 antagonist candidates in a model of hyperlipidemia.
› Verified 9 days ago
Brenda Salcedo, Counselor Medicare: Not Enrolled in Medicare Practice Location: 650 Clark Way, Palo Alto, CA 94304 Phone: 650-617-3834 | |
Dr. Stacy Duffy, PSY.D. Counselor Medicare: Not Enrolled in Medicare Practice Location: 555 Middlefield Rd # 210, Palo Alto, CA 94301 Phone: 650-485-3812 | |
Leonardo Naresh Juarez Diaz, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2741 Middlefield Rd Ste 102, Palo Alto, CA 94306 Phone: 650-798-6330 | |
Jasmine Pereira, Counselor Medicare: Not Enrolled in Medicare Practice Location: 652 Forest Ave, Palo Alto, CA 94301 Phone: 650-323-1401 Fax: 408-642-6052 | |
Elisabeth Myers Dutton, LMFT Counselor Medicare: Not Enrolled in Medicare Practice Location: 260 Sheridan Ave Ste 214, Palo Alto, CA 94306 Phone: 650-746-4230 | |
Miss Olivia Kathleen Mazur Mcdonald, M.A. Counselor Medicare: Not Enrolled in Medicare Practice Location: 650 Clark Way, Palo Alto, CA 94304 Phone: 650-326-5530 |